Illustration: Sarah Grillo/Axios

Even if the Trump administration is able to implement its latest plan to let people import prescription drugs from Canada, it probably won't make much of a difference, experts say.

Between the lines: Canada doesn't have nearly enough drugs to meet American demand, and even if it did, it doesn't want to send them to us at the expense of its own market.

Details: The administration unveiled two paths to importation yesterday.

  • States, wholesalers or pharmacists can ask the federal government to approve a demonstration project, only including certain drugs, only from Canada.
  • Drug companies could import their own products from other countries, at the lower prices they charge there.

Yes, but: "Canada is a much smaller country than is the United States ... and at least some stakeholders have argued that the Canadian market cannot supply medicines to the much larger US market without experiencing drug shortages," Washington University law professor Rachel Sachs wrote in Health Affairs over the summer.

Go deeper: We can't just take Canada's drugs

Go deeper

The Biden blowout scenario

Joe Biden speaks at an outdoor Black Economic Summit in Charlotte yesterday. Photo: Kevin Lamarque/Reuters

Joe Biden or President Trump could win the election narrowly — but only one in a popular and electoral vote blowout. 

Why it matters: A Biden blowout would mean a Democratic Senate, a bigger Democratic House and a huge political and policy shift nationwide.

Justice's moves ring Big Tech with regulatory threats

Illustration: Annelise Capossela/Axios

The Department of Justice proposed legislation to curb liability protections for tech platforms and moved a step closer toward an antitrust lawsuit against Google Wednesday.

The big picture: As President Trump faces re-election, lawmakers and regulators are hurriedly wrapping up investigations and circling Big Tech with regulatory threats.

Democrats' mail voting pivot

Illustration: Sarah Grillo/Axios

Democrats spent the early months of the coronavirus pandemic urging their base to vote absentee. But as threats of U.S. Postal Service delays, Team Trump litigation and higher ballot rejection rates become clearer, many are pivoting to promote more in-person voting as well.

Why it matters: Democrats are exponentially more likely to vote by mail than Republicans this year — and if enough mail-in ballots are lost, rejected on a technicality or undercounted, it could change the outcome of the presidential election or other key races.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!